Risk that R&D results fail to contribute to business performance
First written in FY2016. 25 of 26 entries say "Restated". Latest entry: FY2024.
The whole theme swung hardest in 2026: 15 of 32 companies on the "Worse" side.
79 other companies' latest entry also says "Restated".
- FY2024RestatedAnnual report
「The Group's R&D activities may not necessarily contribute to its operating performance.」
The possibility that R&D results will not translate into market support or improved operating performance continues to be disclosed. - FY2024-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The risk that R&D results will not contribute to operating performance is stated as having no new occurrences or material changes. - FY2024-Q2RestatedAnnual report
「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The risk that R&D results will not contribute to operating performance is stated as having no new occurrences or material changes. - FY2024-Q1RestatedAnnual report
「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The risk that R&D results will not contribute to operating performance is stated as having no new occurrences or material changes. - FY2023-Q2RestatedAnnual report
「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The risk that R&D results will not contribute to operating performance is stated as having no new occurrences or material changes. - FY2023-Q1RestatedAnnual report
「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The risk that R&D results will not contribute to operating performance is stated as having no new occurrences or material changes. - FY2022-Q1RestatedAnnual report
「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The risk that R&D results will not contribute to operating performance is stated as having no new occurrences or material changes. - FY2021-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The risk that R&D results will not contribute to operating performance is stated as having no new occurrences or material changes. - FY2021-Q2RestatedAnnual report
「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The risk that R&D results will not contribute to operating performance is stated as having no new occurrences or material changes. - FY2021-Q1RestatedAnnual report
「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The risk that R&D results will not contribute to operating performance is stated as having no new occurrences or material changes. - FY2020RestatedAnnual report
「The Group's R&D activities may not necessarily contribute to its operating performance.」
The possibility that R&D results will not translate into market support or improved operating performance continues to be disclosed. - FY2020-Q3RestatedAnnual report
「No new business or other risks arose during the cumulative third quarter. There have also been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risk that R&D results will not contribute to operating performance is stated as having no new occurrences or material changes. - FY2020-Q2RestatedAnnual report
「There were no newly arising business or other risks during the cumulative consolidated period of the second quarter. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The risk that R&D results will not contribute to operating performance is stated as having no new occurrences or material changes. - FY2020-Q1RestatedAnnual report
「There were no newly arising business or other risks during the cumulative consolidated period of the first quarter. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The risk that R&D results will not contribute to operating performance is stated as having no new occurrences or material changes. - FY2019RestatedAnnual report
「The Group's R&D activities may not necessarily contribute to its operating performance.」
The possibility that R&D results will not translate into market support or improved operating performance continues to be disclosed. - FY2019-Q3RestatedAnnual report
「No new business or other risks arose during the cumulative third quarter. There have also been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risk that R&D results will not contribute to operating performance is treated as having undergone no material changes. - FY2019-Q2RestatedAnnual report
「There were no newly arising business or other risks during the cumulative consolidated period of the second quarter. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The risk that R&D results will not contribute to operating performance is treated as having undergone no material changes. - FY2019-Q1RestatedAnnual report
「There were no newly arising business or other risks during the cumulative consolidated period of the first quarter. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The risk that R&D results will not contribute to operating performance is treated as having undergone no material changes. - FY2018-Q3RestatedAnnual report
「No new business or other risks arose during the cumulative third quarter. There have also been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risk that R&D results will not contribute to operating performance is treated as having undergone no material changes. - FY2018-Q2RestatedAnnual report
「There were no newly arising business or other risks during the cumulative consolidated period of the second quarter. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The risk that R&D results will not contribute to operating performance is treated as having undergone no material changes. - FY2018-Q1RestatedAnnual report
「There were no newly arising business or other risks during the cumulative consolidated period of the first quarter. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The risk that R&D results will not contribute to operating performance is treated as having undergone no material changes. - FY2017RestatedAnnual report
「The Group's R&D activities may not necessarily contribute to its operating performance.」
The possibility that R&D results will not translate into market support or improved operating performance continues to be disclosed. - FY2017-Q3RestatedAnnual report
「No new business or other risks arose during the cumulative third quarter. There have also been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risk that R&D results will not contribute to operating performance is treated as having undergone no material changes. - FY2017-Q2RestatedAnnual report
「There were no newly arising business or other risks during the cumulative consolidated period of the second quarter. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The risk that R&D results will not contribute to operating performance is treated as having undergone no material changes. - FY2017-Q1RestatedAnnual report
「There were no newly arising business or other risks during the cumulative consolidated period of the first quarter. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The risk that R&D results will not contribute to operating performance is treated as having undergone no material changes. - FY2016First statedAnnual report
「Advances in technology and the emergence of alternative technologies and products may cause changes in the period during which the market supports them, and the Group's R&D activities may not necessarily contribute to its operating performance.」
While identifying the development of cutting-edge gas sensors and new products as key priorities, the company identifies technology substitution and changes in the period of market support as risks.